2 completed, 1 terminated, 1 unknown. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Terminated 1, Unknown 1 |
Follow DAPT: new trials by email Literature Review of DAPT trials Research Report on DAPT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| XIENCE 28 Global Study XIENCE, DAPT - Bleeding Disorder, Stroke, Ischemic | Not applicable | Completed | Abbott Medical Devices | 963 | 2018-02-09 | 2021-03-04 |
| XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients. XIENCE, DAPT - Coronary Artery Lesions | Not applicable | Completed | Abbott Medical Devices | 2047 | 2017-07-19 | 2021-11-05 |
| Xience Versus Synergy in Left Main PCI Percutaneous coronary intervention, Dual antiplatelet therapy - Coronary Artery Disease | Not applicable | Unknown | NHS National Waiting Times Centre Board | 818 | 2014-12-01 | 2014-12-01 |
| COBRA SHIELD OCT Study Aspirin, Resolute Integrity DES, COBRA PzF - Stable Angina | Not applicable | Terminated | CeloNova BioSciences, Inc. | 8 | 2014-06-01 | 2020-10-06 |
Coronary Artery Disease (2) · Anemia (1) · Angina, Stable (1) · Hematologic Diseases (1) · Hemorrhagic Stroke (1) · Hemostatic Disorders (1) · Ischemic Stroke (1) · Renal Insufficiency (1) · Thrombocytopenia (1)
Abbott Medical Devices (2) · CeloNova BioSciences, Inc. (1) · NHS National Waiting Times Centre Board (1)
Austria (1) · Belgium (1) · China (1) · Finland (1) · Germany (1) · Hong Kong (1) · Italy (1) · Netherlands (1) · Portugal (1) · Singapore (1) · Spain (1) · Switzerland (1) · Taiwan (1) · United Kingdom (1) · United States (1)
Marco Valgimigli, MD (1) · Pasi Karjalainen, MD, PhD (1) · Roxana Mehran (1)